Genetics Generation Advancement Corp. (TPEX:4160)
Taiwan · Delayed Price · Currency is TWD 39.40
-0.10 (-0.25%)
Aug 19, 2026, 10:25 AM CST
TPEX:4160 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 614.42 | 603.11 | 661.86 | 592.5 | 547.81 | 519.51 | |
Revenue Growth | 0.10% | -8.88% | 11.71% | 8.16% | 5.45% | 17.24% |
Cost of Revenue | 360.63 | 352.67 | 381.84 | 355.67 | 321.37 | 324.02 |
Gross Profit | 253.79 | 250.44 | 280.01 | 236.83 | 226.44 | 195.49 |
Selling, General & Admin | 186.17 | 174.76 | 166.88 | 164.46 | 153.25 | 149 |
Research & Development | 65.1 | 62.89 | 63.6 | 54.47 | 52.32 | 51 |
Operating Expenses | 252.22 | 238.62 | 230.48 | 218.25 | 206.28 | 200.02 |
Operating Income | 1.57 | 11.82 | 49.53 | 18.58 | 20.15 | -4.53 |
Interest Expense | -1.7 | -0.64 | -0.52 | -0.42 | -0.11 | -0.04 |
Interest & Investment Income | 6.08 | 6.3 | 5.21 | 5.12 | 2.77 | 1.65 |
Currency Exchange Gain (Loss) | -1.15 | -1.15 | 2.77 | 0.29 | 3.49 | -1.95 |
Other Non Operating Income (Expenses) | 13.83 | 10.33 | 9.53 | 10.05 | 9.42 | 14.92 |
EBT Excluding Unusual Items | 18.63 | 26.67 | 66.51 | 33.62 | 35.72 | 10.06 |
Gain (Loss) on Sale of Investments | 0.75 | 0.75 | 0.49 | 1.12 | -2.53 | 0.14 |
Gain (Loss) on Sale of Assets | 0 | 0 | 0.38 | - | - | - |
Pretax Income | 19.38 | 27.42 | 67.39 | 34.74 | 33.19 | 10.2 |
Income Tax Expense | 1.26 | 5.96 | 12.53 | 5.97 | 7.24 | 2.19 |
Earnings From Continuing Operations | 18.13 | 21.46 | 54.86 | 28.77 | 25.95 | 8.01 |
Minority Interest in Earnings | -0.19 | -0.08 | -0.16 | -0.2 | -0.22 | -0.17 |
Net Income | 17.93 | 21.37 | 54.7 | 28.57 | 25.73 | 7.84 |
Net Income to Common | 17.93 | 21.37 | 54.7 | 28.57 | 25.73 | 7.84 |
Net Income Growth | -44.15% | -60.93% | 91.49% | 11.01% | 228.24% | - |
Shares Outstanding (Basic) | 27 | 27 | 27 | 27 | 27 | 27 |
Shares Outstanding (Diluted) | 27 | 27 | 27 | 27 | 27 | 27 |
Shares Change | -0.17% | -0.25% | -0.01% | -0.10% | 0.41% | 0.19% |
EPS (Basic) | 0.67 | 0.80 | 2.05 | 1.07 | 0.96 | 0.29 |
EPS (Diluted) | 0.67 | 0.80 | 2.04 | 1.06 | 0.96 | 0.29 |
EPS Growth | -44.17% | -60.78% | 92.45% | 10.26% | 230.72% | - |
Free Cash Flow | -31 | -43.75 | 55.73 | 63.13 | 44.76 | -0.63 |
Free Cash Flow Per Share | -1.16 | -1.64 | 2.08 | 2.35 | 1.67 | -0.02 |
Dividend Per Share | - | - | 1.850 | 0.485 | 0.436 | 0.264 |
Dividend Growth | - | - | 281.13% | 11.30% | 65.50% | - |
Gross Margin | 41.31% | 41.52% | 42.31% | 39.97% | 41.34% | 37.63% |
Operating Margin | 0.26% | 1.96% | 7.48% | 3.14% | 3.68% | -0.87% |
Profit Margin | 2.92% | 3.54% | 8.26% | 4.82% | 4.70% | 1.51% |
Free Cash Flow Margin | -5.05% | -7.25% | 8.42% | 10.65% | 8.17% | -0.12% |
EBITDA | 20.71 | 25.29 | 57.22 | 24.81 | 26.7 | 1.79 |
EBITDA Margin | 3.37% | 4.19% | 8.64% | 4.19% | 4.87% | 0.34% |
D&A For EBITDA | 19.14 | 13.47 | 7.69 | 6.23 | 6.55 | 6.32 |
EBIT | 1.57 | 11.82 | 49.53 | 18.58 | 20.15 | -4.53 |
EBIT Margin | 0.26% | 1.96% | 7.48% | 3.14% | 3.68% | -0.87% |
Effective Tax Rate | 6.49% | 21.75% | 18.59% | 17.20% | 21.82% | 21.47% |